Dolmatova Elena V, Moazzami Kasra, Cocke Thomas P, Elmann Elie, Vaidya Pranay, Ng Arthur F, Satya Kumar, Narayan Rajeev L
Hackensack University Medical Center, Hackesack, NJ, USA; Rutgers New Jersey Medical School, Newark, NJ, USA.
Hackensack University Medical Center, Hackesack, NJ, USA; Valley Medical Group and Valley Hospital, Ridgewood, NJ, USA.
Heart Lung. 2017 Mar-Apr;46(2):106-109. doi: 10.1016/j.hrtlng.2016.11.005. Epub 2017 Jan 4.
Extracorporeal Membrane Oxygenation (ECMO) has been suggested for cardiopulmonary support in patients with massive pulmonary embolism (PE) refractory to other treatment or as bridging to embolectomy. The survival benefit from ECMO in patients with massive PE remains unclear.
Here, we describe 5 cases in which ECMO was used as cardiopulmonary support following massive near-fatal pulmonary embolism.
The overall mortality in patients with massive PE that received ECMO support was 40%. Death occurred secondary to ECMO-related complication in one case and due to inability to maintain adequate cerebral perfusion despite ECMO support in the second case.
ECMO can be considered as a treatment modality for patients with massive PE.
对于其他治疗无效的大面积肺栓塞(PE)患者或作为桥接至栓子切除术的患者,有人建议使用体外膜肺氧合(ECMO)进行心肺支持。ECMO对大面积PE患者的生存益处仍不明确。
在此,我们描述了5例在发生近乎致命的大面积肺栓塞后使用ECMO进行心肺支持的病例。
接受ECMO支持的大面积PE患者的总死亡率为40%。1例死亡继发于ECMO相关并发症,另1例死亡是由于尽管有ECMO支持但仍无法维持足够的脑灌注。
ECMO可被视为大面积PE患者的一种治疗方式。